FlandersBio offers an up-to-date life sciences database with detailed information about all FlandersBio members.
FlandersBio beschikt over een geüpdate life sciences databank met een gedetailleerd overzicht van alle FlandersBio-ledenbedrijven.
CHHC, as part of HM3A, is a member of the global Agora Consulting network (www.agora-consulting.org). Its main focus is to draft valuable market access strategies for Biotech companies on a global and local scale.
A broad range of services is offered such as developing a fully fledged marketing and financial plan for venture funding, market resaerch,medical support including phamracovigilance, Risk Management plan and others.
Strategic market access advice:
The most optimal market access pathway is proposed based on an in depth understanding, analysis and mapping of all relevant stakeholders in the healthcare industry. Together with the client the implementation plan is proposed and followed up until conclusion.
We will establish a targeted stakeholder map, define leverages of influences between stakeholders and work out the key messages that must be conveyed to target audience in order to demonstrate the core value. Managing this process is what makes CHHC unique.
Managing all complexities inherent to market access will be ensured with full control and thanks to the determination of key milestones. Projects can be managed from central location in Europe for several markers or in market thanks to a network of high performing consultants.
Do you have a new therapy that has a challenge finding its way to the market? CHHC can surely help you finding the right target customer base and propose you a viable business model that helps establish your brand and successfully bring your product to the market.